Subscribe: Biotech-Healthcare/Biotech-News By Industry-News-The Economic Times
Added By: Feedage Forager Feedage Grade A rated
Language: English
biocon received  biocon  biotech  company  drug  government puts  insulin glargine  insulin  market  monsanto  new  product insulin  product  sell 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotech-Healthcare/Biotech-News By Industry-News-The Economic Times

Biotech-Healthcare/Biotech-Industry-The Economic Times

The Economic Times: Latest business, finance, markets, stocks, company news from India.

Last Build Date: Tue, 17 Jan 2017 17:20:52 GMT

Copyright: Copyright:(C)2017 Bennett Coleman & Co. Ltd,

Norms eased for makers of biologic products

Fri, 16 Dec 2016 19:35:12 GMT

(image) CDSCO has done away with the need for joint inspections to issue licences to allow such companies to make biologic products for testing and analysis purposes.

Carlyle Group emerges front-runner for Bharat Biotech stake

Thu, 04 Aug 2016 10:45:14 GMT

(image) The firm counts domestic private equity fund ICICI Ventures, International Finance Corp, the global investment arm of the World Bank and Subhkam Ventures as its investors.

EMA accepts marketing application of Biocon, Mylan product

Thu, 21 Jul 2016 16:00:38 GMT

(image) Mylan and Biocon, who co-developed the proposed biosimilar, received EMA's acceptance of the submission for review, Biocon said in a statement.

Monsanto to consider Bayer's revised proposal for acquisition

Fri, 15 Jul 2016 14:49:06 GMT

(image) Bayer had raised its all-cash offer to Monsanto shareholders from $ 122 to $ 125/share. It also offered a $ 1.5-billion reverse anti-trust break fee.

Biocon's partner firm launches diabetes product in Japan

Fri, 15 Jul 2016 07:19:24 GMT

(image) In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.

West Bengal to set up three biotechnology hubs

Thu, 07 Jul 2016 12:25:34 GMT

(image) Biotechnology Dept of the State has already taken up an elaborate scheme to not only tie up with other departments like Agriculture, Fisheries and Food Processing.

Biocon, Quark get DCGI nod for trials of new eye disease drug

Thu, 23 Jun 2016 07:08:50 GMT

(image) Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy."

GEAC defers decision on commercial cultivation of GM mustard

Mon, 20 Jun 2016 16:58:13 GMT

(image) Biotech regulator GEAC today deferred its decision on commercial cultivation of genetically modified (GM) mustard in the country.

New drug, vaccines to get booster dose from government

Tue, 07 Jun 2016 01:48:20 GMT

(image) DBT is looking to invest in a programme to expand the existing centres for drug and vaccine research which will take up the possibility of investing.

Stempeutics research gets DCGI nod for stem cell based product

Mon, 30 May 2016 08:42:52 GMT

(image) The company's goal is to globalise Stempeucel for Buerger's Disease and the market size is approximately $ 1.5 billion worldwide.

Government puts off GM cotton seed order, eases pressure on Monsanto

Mon, 23 May 2016 16:06:00 GMT

(image) In an order last week, the farm ministry said any company providing any new, advanced variety of GM cotton would not be allowed to charge royalties.

Modi government puts a sales squeeze on world's biggest seed company Monsanto

Sat, 21 May 2016 05:23:20 GMT

(image) The move will cap royalties for any new variety that the market's sole supplier - US-based Monsanto Co - decides to develop and sell.

Australia, India to work together to improve sugarcane varieties

Fri, 29 Apr 2016 10:27:30 GMT

(image) The project will identify genetic markers for cane yield, sugar content, drought tolerance and red rot resistance, in sugarcane varieties.

Biocon gets nod to sell its diabetes product 'Insulin Glargine' in Japan

Mon, 28 Mar 2016 10:35:44 GMT

(image) Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.

Biocon links with Mexico's PiSA to tap US insulin market

Thu, 17 Mar 2016 06:19:19 GMT

(image) Biocon said it has entered into a co-development and commercialization alliance with PiSA of Mexico for recombinant human insulin aimed at the US market.